Sign Up
English English
en Englishfr French
  • Technologies
      • Back
      • VersaFilm™
      • VetaFilm
      • VevaDermTM
  • Product Development
      • Back
  • Analytical Development And Testing
      • Back
  • Manufacturing
      • Back
      • Supply chain
      • Manufacturing & Packaging
  • Products
      • Back
  • Partnering
      • Back
      • Trade Shows
      • BD Contacts
  • Governance
      • Back
      • Corporate Governance
  • Investors
      • Back
      • Stock Price
          • Back
          • OTCQX: IGXT
          • TSX-V: IGX
      • Regulatory Filings
          • Back
      • Events
          • Back
          • 2020
          • 2019
          • 2021
      • Investor Relations
      • Analyst Coverage
      • Webcast
      • Investor Presentations
      • Investor FAQs
  • Contact Us
  • Careers
  • Newsroom
      • Back
      • Press Release
          • Back
          • 2020
          • 2019
          • 2018
          • 2017
          • 2016
          • 2015
          • Archive
          • 2022
          • 2021
          • 2023
          • 2025
          • 2024
      • In the News
  • Sign Up
  • Search Icon
  • Linkedin Icon
  • Twitter Icon
http://intelgenx.com
    • TECHNOLOGIES

      IntelGenx’s Superior Film Technologies

       
      • Back
      • VersaFilm®
      • VetaFilmTM
      • VevaDermTM
       
    • Manufacturing

      IntelGenx’s highly skilled team provides technological expertise in scale-up, technology transfer and manufacturing of pharmaceutical films.

       
      • Back
      • Overview
      • Supply chain
      • Manufacturing & Packaging
    • Partnering

       

       
      • Back
      • Overview
      • Trade Shows
      • BD Contacts
       
      • Back
 

INVESTORS

IntelGenx Technologies Corp.

IntelGenx Presentations

Presentations

View all presentations >>

Latest Corporate

Presentation >>

 

 

 

 

Recent press releases

  • 02 Oct 2024 IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG
  • 19 Jul 2024 IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process
  • 03 Jul 2024 IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

 

VIELL ALL >>

Events

  • 13 Aug 2020 IntelGenx Reports Third Quarter 2020 Financial Results
  • 13 Aug 2020 IntelGenx Reports Second Quarter 2021 Financial Results

 

 

 

2ST QUARTER 2020

 

10-Q

View>>

Press Release

View>>

Webcast

View>>

 

 

 

IntelgenX
Terms of service | Privacy | Contact Us 
© 2025 Copyright - IntelGenx Corp.
Site & CMS By Sandman Media Inc